FreeStyle Libre 3
Device Diabetes Care
PDI 00357599819002
General payments
$9,531,015
Research payments
$4,943,789
Through program year 2025, $9,531,015 in general payments and $4,943,789 in research payments were reported against FreeStyle Libre 3 (Diabetes Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,736,817 | 62,553 |
| 2025 | Research | $3,944,118 | 314 |
| 2024 | General | $3,227,758 | 74,236 |
| 2024 | Research | $314,046 | 55 |
| 2023 | General | $2,566,441 | 63,730 |
| 2023 | Research | $685,625 | 50 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 175 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 55 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
200,519 general · 419 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.